浅析通心络治疗心脑血管疾病临床疗效研究.docVIP

浅析通心络治疗心脑血管疾病临床疗效研究 　　【摘要】目的 对通心络用于治疗心脑血管疾病的临床效果进行深入探讨和剖析。方法 将我院自2012年4月至2014年2月一年间所接收的心脑血管疾病患者共172例，将其随机分为两组，即治疗组和对照组，两组均为86例患者。对治疗组患者给予口服通心络胶囊治疗，对对照组患者给予银杏叶片治疗，并将治疗一段时间后两组患者的恢复情况进行对比。结果 经过一段时间的治疗后，治疗组的86例患者中有54例患者疗效显著（62.79%），25例患者治疗有效（29.06%），7例患者治疗无效（8.10%），总有效率为91.86%。对照组的86例患者中有31例患者疗效显著（36.04%），30例患者治疗有效（34.88%），25例患者治疗无效（29.06%），总有效率为70.93%。两组对比明显（P≤0.05），具有统计学意义。结论 通心络用于治疗心血管疾病是极为有效的，且存在较少的副作用，值得在临床上进行推广和应用。 　　【关键词】通心络；心脑血管疾病；临床疗效；对比；分析 　　【Abstract】objective to in-depth study and analysis of Tongxinluo clinical results for the treatment of cardiovascular and cerebrovascular diseases. Method in our hospital from 2012 April to 2014 February year received cardio cerebral vascular disease in patients with a total of 172 cases， which were randomly divided into two groups， treatment group and control group， two groups of 86 patients. The patients in the treatment group were treated with Tongxinluo capsule treatment， the patients in control group were treated with Ginkgo biloba in the treatment， and the treatment for a period of time after the two groups of patients recover compared. Results after a period of treatment， 86 cases of treatment group patients had significantly effect in 54 patients （62.79%）， 25 patients with effective treatment （29.06%）， invalid in 7 patients （8.10%）， the total efficiency is 91.86%. 86 cases of the control group patients had significantly effect in 31 patients （36.04%）， 30 patients with effective treatment （34.88%）， invalid in 25 patients （29.06%）， the total efficiency is 70.93%. Two groups of contrasts （P≤0.05）， with statistical significance. Conclusion Tongxinluo capsule for the treatment of cardiovascular disease is very effective， and has fewer side effects， is worthy of promotion and application in clinical. 　　【key words 】 Tongxinluo； cardiovascular disease； clinical curative effect； comparison； analysis 　　【中图分类号】R259 　　【文献标识码】B 　　【文章编号】1004-4949（2014）12-0065-02 　　引言：心脑血管疾病主要是由于血管壁平滑肌细胞非正常代谢造成的，但不良的饮食习惯和生活习惯或缺失合理的运动等也是引